Yes, a thyroid scan and radioactive iodine uptake (RAIU) are different but complementary tests that are often performed together.
A radioactive iodine uptake (RAIU) measures thyroid function by quantifying the percentage of administered radiotracer that the thyroid gland concentrates over time (typically at 24 hours), while a thyroid scan provides anatomic imaging that shows the distribution pattern of radiotracer uptake throughout the thyroid gland 1.
Key Differences
RAIU (Functional Measurement)
- Quantifies thyroid activity by measuring the percentage of radioiodine absorbed by the thyroid
- Provides a numerical value (e.g., 5%, 35%, 60%)
- Directly measures thyroid metabolic function
- Essential for calculating therapeutic radioiodine doses 2
Thyroid Scan (Anatomic Imaging)
- Visualizes the spatial distribution of radiotracer within the thyroid
- Shows whether uptake is diffuse (as in Graves' disease) or focal (as in toxic adenoma or multinodular goiter)
- Identifies "hot" (hyperfunctioning) versus "cold" (hypofunctioning) nodules
- Confirms tissue is thyroid in origin 1
When Both Are Performed Together
The ACR Appropriateness Criteria recommend performing "radionuclide uptake and scan" as a combined study in specific clinical scenarios 1:
Primary Indications:
- Thyrotoxicosis evaluation: When the etiology is unclear (distinguishing Graves' disease from toxic adenoma, toxic multinodular goiter, or thyroiditis) 1
- Goiter with thyrotoxicosis: To confirm the entire goiter consists of thyroid tissue and identify which nodules are hyperfunctioning 1
- Planning radioiodine therapy: The RAIU measurement is necessary for dose calculation 2, 3
Technical Consideration:
Iodine-123 (I-123) is preferred over iodine-131 (I-131) because of superior imaging quality for the scan component 1.
Clinical Context
In practice, when clinicians order a "radioiodine uptake and scan," they receive:
- A numerical RAIU value indicating thyroid function level
- An image showing uptake distribution throughout the gland
The RAIU alone tells you how much the thyroid is working; the scan tells you where that activity is located. For example, in thyrotoxicosis, an elevated RAIU (>30-35%) with diffuse uptake on scan suggests Graves' disease, while elevated RAIU with focal uptake suggests toxic adenoma 2, 4.
Important Caveats
- For euthyroid nodular disease: Neither test is indicated, as fine-needle aspiration is the appropriate initial evaluation 5, 6
- For hypothyroidism: Neither test has any role, as all causes show decreased uptake 1
- Geographic variation: RAIU normal ranges vary by region based on dietary iodine intake, and the test's diagnostic utility has decreased in iodine-sufficient areas 3